Nelson Griswold

Commentary: He’ll tell you his efforts were imperfect. And he didn’t get to everything. But what one adviser did do — his commitment to action, to implementation — produced 55% growth in 24 months.

Commentary: Benefit firms hoping for agency growth must manage their producers or suffer the consequences of relinquishing control of the firm’s future, says EBA columnist Nelson Griswold.

Commentary: EBA columnist Nelson Griswold says benefits RFPs are universally awful and HR should abandon them. Advisers, he says, should also be wary of them.

Commentary: The broker’s dependence on the medical carriers — and their value to the broker’s business business — has about run its course, says columnist Nelson Griswold.

Commentary: Brokers across the country have horror stories of Zenefits stealing their clients. So, columnist Nelson Griswold asks, what can a broker or adviser do to defend his book from Zenefits?

Commentary: Columnist Nelson Griswold discusses why sophisticated employee benefit advisers are increasingly discussing self-funding of the health plan with mid-size employers.

Commentary: What should brokers and benefit advisers take away from all the merger and acquisition activity among the medical carriers? The message is crystal clear. Now would be the time to move away from a dependency on medical commissions and take a fee.

Commentary: With their merger, both Willis and Towers Watson are playing offense, creating a synergy that strengthens both firms by combining the unique strengths of each … the brokerage experience of Willis and the analytical, consultative services of Towers Watson.

Commentary: The ACA is “unremovable,” says columnist Nelson Griswold, so advisers must learn how to leverage it.

Commentary: By reframing and renaming these benefits, you can avoid any knee-jerk reaction to or bias against “voluntary benefits,” says columnist Nelson Griswold.